Most of us are excited about the changes occurring in healthcare around mobile applications, electronic health records and the advent of social media just to name a few examples. Yet there is a mounting concern with the rise of drug shortages now reported at “178 a 3x rise since 2005!” A look at the FDA web site Read More
Category: Innovation
Managing my data…
We are not at a point where we can effectively: total, safely protect, easily transport and access our health data. I read a great article by Margalit Gur-Arie entitled, “Trust your life records to an unnamed chain of software vendors” she uses an analogy of our current banking system to emphasize how far away we Read More
Fresh start in 2011
By now everyone has gotten past their New Year’s resolutions and is picking up where they left off last year. So thinking about my first blog post for 2011 I would like to cover the following areas: A look back at 2010 Maintaining momentum in 2011 The focus for the year Reviewing 2010 The nice Read More
5 Steps for IT to meet the Challenges of Patent Expiry
We have heard a lot about the ‘patent expiry’ problem within the industry. Here are 5 +1 steps your IT team can take to help improve a company’s position to meet this challenge. As revenues decline as a result of ‘patent expiry’ there is an associated ‘cost reduction’ that is taking place. This is not Read More
Aligning Life Sciences and Healthcare IT. Part 3 Innovation and the Business Process
This is the last installment on Aligning Life Sciences and Healthcare IT. I had written two earlier blog posts on Innovation back on 23Nov2009 The time for ‘Process Innovation’ is now and on 8Dec2009 Pharma 2.0 and the need for Process Innovation. I had been inspired to write about this topic due to a recent set of tweets Read More
IT Innovation and Outsourcing
Cost pressures have forced companies to ‘outsource’ a variety of IT services. How much information technology (IT) to outsource depends on which industry you are in and to what extent IT plays a part in your end product or service. Many of our clients have to balance this decision, and surprisingly there are advantages to outsourcing as it focuses an organization on IT innovation in support of the business goals.
Deriving “value” in today’s world of Social Media
The focus on this article is to help you find “value” through the use of social media tools. The idea came to me when I read the Community Pharm post entitled “Hindsight Is 20-20 But Foresight Is Critical.” In this article, the main idea was on the Pharmaceutical brand manager’s focus on budgeting. I want to discuss ways in which this budget can be applied to activities that ultimately add ‘value,’ and how you can find ways to apply social media tools to drive revenue your products.
Aligning Life Sciences and Healthcare IT. Part 2 A Practical Mobility Solution for Doctors and Nurses.
In a previous blog post I introduced the ‘value chain’ for these industries, and discussed lessons learned from Life Sciences IT to help Healthcare IT in the use of technology. In Part 2 I am providing a practical application on the use of handheld (mobile) devices being used by doctors and nurses for ‘intimate healthcare.’ At the end of this article I will provide a link to this ‘case study’ which we have named Patient Monitoring System (PMS).
Aligning Life Sciences and Healthcare IT. Can IT bridge the gap? Part1
What lessons can Healthcare Information Technology (IT) take from the Life Sciences IT? My background has been in Life Sciences and looking into Healthcare I can’t help but notice the similarities and differences in the use of technology. So how do we ‘evolve’ from our current position to fulfill this new ‘model’ of healthcare? In this posting I will focus on the Life Sciences portion of the value chain.
New Research Model to Accelerate Drug Development
Online Webinar (25March2010) on “Developing Cures with Less Time and Capital” discusses a new research model for drug development. With the focus on healthcare costs, what can be done to improve success in developing new treatments? How can this model help the pharmaceutical industry gain a greater ROI around drug development?